Abstract
Most prospective studies of bone mineral density (BMD) in systemic lupus erythematosus (SLE) patients have been of relatively short duration, with a maximum of 6 years. To describe long-term changes in BMD in women with SLE and identify risk factors associated with BMD loss. We retrospectively evaluated 132 adult Mexican-Mestizo women with SLE who underwent dual X-ray absorptiometry (DXA). Demographic and clinical data were collected and BMD at the lumbar spine (L1–L4) and total hip were collected at baseline and during the follow up. At baseline, the mean age of participants was 43.4 ± 12.5 years, 50.8% had osteopenia and 11% osteoporosis. The median follow-up was 13 (IQR 10.2–14.0) years. During follow up, 79% of patients used glucocorticoid (GCT). The mean percentage of changes in BMD during follow up were: − 14.03 ± 11.25% (− 1.49%/year) at the lumbar spine, and − 15.77 ± 11.57% (− 1.78%/year) at the total hip, with significant changes (p < 0.001 for both comparisons). Multivariate analysis showed older age, GCT use at baseline, and transition to the menopause during the follow-up were significantly associated with greater reductions in BMD. This retrospective longitudinal study found significant BMD loss at the lumbar spine and hip. Older age, menopausal transition and GCT use were independently associated with BMD decline in women with SLE.
Similar content being viewed by others
References
Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R et al (2010) European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 69:1269–1274. https://doi.org/10.1136/ard.2009.117200
Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S et al (2018) Canadian Rheumatology Association recommendations for the assessment and monitoring of systemic lupus erythematosus. J Rheumatol 45:1426–1439. https://doi.org/10.3899/jrheum.171459
Kalla AA, Fataar AB, Jessop SJ, Bewerunge L (1993) Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 36:1726–1734
Pineau CA, Urowitz MB, Fortin PJ et al (2004) Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density. Lupus 13:436–441. https://doi.org/10.1191/0961203303lu1036oa
Almehed K, Forsblad d’Elia H, Kvist G, Ohlsson C, Carlsten H (2007) Prevalence and risk factors of osteoporosis in female SLE patients—extended report. Rheumatology 46:1185–1190. https://doi.org/10.1093/rheumatology/kem105
Bultink IEM, Lems WF, Kostense PJ, Dijkmans B, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52:2044–2050. https://doi.org/10.1002/art.21110
Mendoza-Pinto C, García-Carrasco M, Sandoval-Cruz H, Escárcega RO, Jiménez-Hernández M, Etchegaray-Morales I et al (2009) Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus. Clin Rheumatol. https://doi.org/10.1007/s10067-008-0984-z
Jardinet D, Lefebvre C, Depresseux G et al (2000) Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine. Rheumatology (Oxford, England) 39:389–392
Boyanov M, Robeva R, Popivanov P (2003) Bone mineral density changes in women with systemic lupus erythematosus. Clin Rheumatol 22:318–323. https://doi.org/10.1007/s10067-003-0743-0
Jacobs J, Korswagen LA, Schilder AM, Van Tuyl LH, Dijkmans BAC, Lems WF et al (2013) Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int 24:1827–1833. https://doi.org/10.1007/s00198-012-2157-9
Zhu TY, Griffith JF, Au S-K, Tang X-L, Kwok AW, Leung P-C et al (2014) Bone mineral density change in systemic lupus erythematosus: a 5-year followup study. J Rheumatol 41:1990–1997. https://doi.org/10.3899/jrheum.131190
Bultink IEM, Lems WF (2015) Systemic lupus erythematosus and fractures. RMD Open 1:e000069. https://doi.org/10.1136/rmdopen-2015-000069
Mendoza-Pinto C, García-Carrasco M, Sandoval-Cruz H, Muñoz-Guarneros M, Escárcega RO, Jiménez-Hernández M et al (2009) Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol 28:579–585. https://doi.org/10.1007/s10067-009-1105-3
García-Carrasco M, Mendoza-Pinto C, León-Vázquez ML, Méndez-Martínez S, Etchegaray-Morales I, Montiel-Jarquín Á et al (2017) Incidence of vertebral fractures in women with systemic lupus erythematosus after 8 years of follow-up. Calcif Tissue Int. https://doi.org/10.1007/s00223-017-0286-z
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https://doi.org/10.1002/art.1780400928
Petri M, Orbai A-M, Alarcón GS et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686. https://doi.org/10.1002/art.34473.Derivation
Ceccarelli F, Orefice V, Perrone G, Pirone C, Perricone C, Truglia S et al (2020) Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study. Clin Exp Rheumatol 38:450–454
Guzman J, Cardiel MH, Arce-Salinas A, Sanchez-Guerrero J, Alarcon-Segovia D (1992) Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 19:1551–1558
Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Fortin P, Ginzler E et al (2000) The systemic lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 27:373–376
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281. https://doi.org/10.1136/bmj.318.7193.1284a
Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR et al (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom Off J Int Soc Clin Densitom 22:453–471. https://doi.org/10.1016/j.jocd.2019.07.001
Pons F, Peris P, Guañabens N, Font J, Huguet M, Espinosa G et al (1995) The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 34:742–746. https://doi.org/10.1093/rheumatology/34.8.742
Hansen M, Halberg P, Kollerup G, Pedersen-Zbinden B, Hørslev-Petersen K, Hyldstrup L et al (1998) Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment. Scand J Rheumatol 27:197–206. https://doi.org/10.1080/030097498440813
Kipen Y, Briganti EM, Strauss BJ, Littlejohn GO, Morand EF (1999) Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus. Rheumatology (Oxford) 38:59–65. https://doi.org/10.1093/rheumatology/38.1.59
Ho SC, Chan SG, Yip YB, Chan CSY, Woo JLF, Sham A (2008) Change in bone mineral density and its determinants in pre- and perimenopausal Chinese women: the Hong Kong Perimenopausal Women Osteoporosis Study. Osteoporos Int J Establ Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 19:1785–1796. https://doi.org/10.1007/s00198-008-0614-2
Johansson H, Clark P, Carlos F, Oden A, McCloskey EV, Kanis JA (2011) Increasing age- and sex-specific rates of hip fracture in Mexico: a survey of the Mexican institute of social security. Osteoporos Int 22:2359–2364. https://doi.org/10.1007/s00198-010-1475-z
Karlamangla AS, Burnett-Bowie S-AM, Crandall CJ (2018) Bone health during the menopause transition and beyond. Obstet Gynecol Clin N Am 45:695–708. https://doi.org/10.1016/j.ogc.2018.07.012
Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL et al (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2016. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 22:1–42. https://doi.org/10.4158/EP161435.GL
Mak A, Lim JQ, Liu Y, Cheak AA, Ho RC (2013) Significantly higher estimated 10-year probability of fracture in lupus patients with bone mineral density comparable to that of healthy individuals. Rheumatol Int 33:299–307. https://doi.org/10.1007/s00296-012-2389-1
Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Chadha AB et al (2006) Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology (Oxford) 45:53–60. https://doi.org/10.1093/rheumatology/kei079
Bultink IEM (2018) Bone disease in connective tissue disease/systemic lupus erythematosus. Calcif Tissue Int 102:575–591. https://doi.org/10.1007/s00223-017-0322-z
Mendoza-Pinto C, Rojas-Villarraga A, Molano-González N, Jiménez-Herrera EA, León-Vázquez ML, Montiel-Jarquín Á et al (2018) Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: a systematic review and meta-regression. PloS One 13:e0196113. https://doi.org/10.1371/journal.pone.0196113
McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res Off J Am Soc Bone Miner Res 31:940–948. https://doi.org/10.1002/jbmr.2734
Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE et al (2017) 2017 American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 69:1095–1110. https://doi.org/10.1002/acr.23279
Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12:43. https://doi.org/10.1007/s11657-017-0324-5
Demas KL, Keenan BT, Solomon DH, Yazdany J, Costenbader KH (2010) Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators. Semin Arthritis Rheum 40:193–200. https://doi.org/10.1016/j.semarthrit.2010.01.001
Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J (2010) Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res 62:993–1001. https://doi.org/10.1002/acr.20150
Casey C, Chung CP, Crofford LJ, Barnado A (2017) Rheumatologists’ perception of systemic lupus erythematosus quality indicators: significant interest and perceived barriers. Clin Rheumatol 36:97–102. https://doi.org/10.1007/s10067-016-3487-3
Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N (2001) Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 28:102–108
Mok CC, Mak A, Ma KM (2005) Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus. Lupus 14:106–112. https://doi.org/10.1191/0961203305lu2039oa
Mok CC, Ying SKY, To CH, Ma KM (2008) Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study. Bone 43:327–331. https://doi.org/10.1016/j.bone.2008.04.003
Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW et al (2001) Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 28:2535–2539
Xiu Y, Xu H, Zhao C, Li J, Morita Y, Yao Z et al (2014) Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. J Clin Investig 124:297–310. https://doi.org/10.1172/JCI66947
Both T, Zillikens MC, Schreuders-Koedam M, Vis M, Lam W-K, Weel AEAM et al (2018) Hydroxychloroquine affects bone resorption both in vitro and in vivo. J Cell Physiol 233:1424–1433. https://doi.org/10.1002/jcp.26028
Acknowledgements
The authors thank all patients who participated in the study, which was, in part, supported by a grant from CONCYTEP (Consejo de Ciencia y Tecnologia del Estado de Puebla).
Funding
This study was partly supported by grant from FIS/IMSS/PROT 2018-2106-47. This funding source had no role in the design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.
Author information
Authors and Affiliations
Contributions
CMP, MGC, DJM and PMR contributed to the conception and design of the study and wrote and revised the manuscript. DJM, PMR and MNS, IEM contributed to data collection and analysis. CMP and DMJ made the statistical analysis. IEM, JAA and SMM revised the manuscript. All authors contributed to the critical revision and approved the final version for publication.
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest with respect to the content of the manuscript. Outside the submitted work, Dr García-Carrasco reports royalty payments from UCB for the publication of books/chapters. The remaining authors have no conflict of interests.
Human and Animal Rights and Informed Consent
The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Local Ethics Committee, IMSS (R-2018-2106-035).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mendoza-Pinto, C., García-Carrasco, M., Juárez-Melchor, D. et al. A Retrospective Analysis of Longitudinal Changes in Bone Mineral Density in Women with Systemic Lupus Erythematosus. Calcif Tissue Int 109, 363–371 (2021). https://doi.org/10.1007/s00223-021-00845-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-021-00845-0